T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Mirion Technologies
MIR
$3.83B
| $75K | ﹤0.01% |
+13,070
| New | +$96.2K |
|
2802
MacroGenics
MGNX
$269M
| $74K | ﹤0.01% |
24,988
+300
| +1% | +$1.58K |
|
2803
Energy Fuels
UUUU
$3.6B
| $74K | ﹤0.01% |
15,117
+1,222
| +9% | +$8.65K |
|
|
GOEV
2804
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $74K | ﹤0.01% |
87
-12
| -12% | -$21.1K |
|
|
AIXC
2805
AIxCrypto Holdings Inc
AIXC
$14.9M
| $73K | ﹤0.01% |
258
| – | – |
|
2806
Ring Energy
REI
$347M
| $73K | ﹤0.01% |
27,349
+8,249
| +43% | +$34.1K |
|
2807
Vroom Inc
VRM
$52.6M
| $73K | ﹤0.01% |
731
-3,084
| -81% | -$387K |
|
|
SUNW
2808
DELISTED
Sunworks, Inc.
SUNW
| $73K | ﹤0.01% |
46,200
+1,600
| +4% | +$3.05K |
|
2809
Dare Bioscience
DARE
$20.4M
| $72K | ﹤0.01% |
4,883
| – | – |
|
2810
GrowGeneration
GRWG
$110M
| $70K | ﹤0.01% |
19,522
+2,495
| +15% | +$14.2K |
|
|
VLDR
2811
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $69K | ﹤0.01% |
72,126
-3,761
| -5% | -$6.5K |
|
2812
Ocean Power Technologies
OPTT
$54.6M
| $68K | ﹤0.01% |
119,800
| – | – |
|
2813
Willamette Valley Vineyards
WVVI
$11.8M
| $68K | ﹤0.01% |
10,850
| – | – |
|
2814
Ovid Therapeutics
OVID
$524M
| $67K | ﹤0.01% |
31,133
-6,828
| -18% | -$16.5K |
|
2815
Alto Ingredients
ALTO
$327M
| $66K | ﹤0.01% |
17,694
+200
| +1% | +$1.04K |
|
|
AMPE
2816
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $66K | ﹤0.01% |
1,314
+557
| +74% | +$41.5K |
|
2817
Planet Labs
PL
$8.79B
| $64K | ﹤0.01% |
+14,835
| New | +$76.6K |
|
2818
Porch Group
PRCH
$1.85B
| $64K | ﹤0.01% |
24,808
+442
| +2% | +$1.83K |
|
|
VVNT
2819
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $64K | ﹤0.01% |
18,513
+685
| +4% | +$3.65K |
|
|
REV
2820
DELISTED
Revlon, Inc.
REV
| $64K | ﹤0.01% |
11,800
-566
| -5% | -$3.1K |
|
2821
iQIYI
IQ
$1.29B
| $63K | ﹤0.01% |
14,900
| – | – |
|
2822
PEDEVCO
PED
$162M
| $63K | ﹤0.01% |
2,760
-1,145
| -29% | -$29.3K |
|
2823
Paysafe
PSFE
$371M
| $63K | ﹤0.01% |
2,689
+973
| +57% | +$31.4K |
|
|
CKPT
2824
DELISTED
Checkpoint Therapeutics
CKPT
| $61K | ﹤0.01% |
5,900
| – | – |
|
2825
Lantronix
LTRX
$277M
| $60K | ﹤0.01% |
11,200
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.